News | January 27, 2009

Boston Scientific, Medtronic Reach Agreement on Cardiology, Endovascular Repair Patent Disputes

January 28, 2009 - Boston Scientific Corp. and Medtronic Inc. today announced the settlement of two lawsuits and an agreement to stand down in three others.

These agreements stop all current litigation between the two parties in the fields of interventional cardiology and endovascular repair. All the disputes involved intellectual property.

“We are pleased to have reached these agreements which will allow us to focus our efforts and resources on developing new products and therapies that improve patients’ lives,” said Hank Kucheman, senior vice president and group president, cardiovascular for Boston Scientific.

The stand-down agreements are time limited and involve only Medtronic and Boston Scientific. While the terms of the settlement remain confidential, Boston Scientific said the agreements will not have a material impact on its financial results. The lawsuits are listed below.

For more information: www.bostonscientific.com


Additional Content

News | Stents

Nov. 24, 2025 — InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke ...

Home November 24, 2025
Home
News | Stents

Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...

Home October 13, 2025
Home
News | Stents

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...

Home October 16, 2024
Home
News | Stents

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
News | Stents

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
Subscribe Now